As shown in Fig. 9i to 9l, inhibition of HCG18 or RRM2, or activation of miR-30a-5p significantly decreased the tumor growth, but markedly increased the Fe2+ and MDA induced by erastin in tumor tissues. The gene discussed is HCG18; the disease is neoplasm.